Jim Cramer’s Opinion on 21 Stocks: Oklo, AST SpaceMobile, and Others

Page 15 of 15

6. Eli Lilly and Company (NYSE:LLY)

Eli Lilly and Company (NYSE:LLY) was among the stocks Jim Cramer highlighted, as he discussed the massive AI infrastructure buildout. Cramer noted that the company is “creating a lot of jobs,” as he said:

Okay, then there’s one that’s totally away from manufacturing or industry or tech, and that’s Eli Lilly. It was up 10%. Lilly astounded people today by reporting a fantastic quarter with encouraging prescription data for the new pill form of the GLP-1 drug, Foundayo. There was some worry that this drug had gotten off to a slow start. A lot of rumors going around Wall Street that it was a bummer. Novo Nordisk was said to be way ahead of Lilly because it got approved earlier. As is often the case, the Wall Street gas-bags got it wrong.

When David Ricks, CEO of Lilly, came on CNBC this morning, he said that things were pretty strong. Strong demand for the pill, more than 20,000 people now taking it, even as the company had only just started marketing it and building the brand. That’s good news for my Charitable Trust. We’ve been telling people to stick with Lilly no matter what. Just too much good going on there. I think that Eli Lilly’s gain today is sensational, and this company is creating a lot of jobs… But it is, alas, a healthcare company, and healthcare companies are not indicators of good times. When it comes to the stock market, drug companies, they’re bad leaders.

Eli Lilly and Company (NYSE:LLY) develops and markets medicines for diabetes, obesity, oncology, immunology, neuroscience, and other chronic conditions.

While we acknowledge the potential of LLY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LLY and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see Jim Cramer’s Opinion on 5 Stocks: Arm, Quanta Services, and Others.

Disclosure: None. Follow Insider Monkey on Google News.

Page 15 of 15